发明申请
US20060140960A1 Biomarkers for pre-selection of patients for anti-IGF1R therapy
有权
用于预选抗IGF1R治疗的患者的生物标志物
- 专利标题： Biomarkers for pre-selection of patients for anti-IGF1R therapy
- 专利标题（中）： 用于预选抗IGF1R治疗的患者的生物标志物
-
申请号： US11290687申请日： 2005-11-30
-
公开(公告)号： US20060140960A1公开(公告)日： 2006-06-29
- 发明人: Yan Wang , Jonathan Pachter , Yaolin Wang , Ming Liu
- 申请人： Yan Wang , Jonathan Pachter , Yaolin Wang , Ming Liu
- 专利权人： Schering Corporation
- 当前专利权人： Schering Corporation
- 主分类号： A61K39/395
- IPC分类号： A61K39/395
摘要：
The present invention provides methods for identifying patients whose cancers are likely to be responsive to IGF1R inhibitory anti-cancer therapy along with methods for treating such patients. Patients identified by a method of the present invention can be treated with any of several known IGF1R inhibitory agents including antibodies, small molecule inhibitors and anti-sense nucleic acids.
公开/授权文献
信息查询
